Many thanks Christoph and Fulya,

My only comment at this point would be that the key message that we want to convey (i.e. that the EP gets aware of the risk that CRISPR industry will take over conventional breeding if patents on random mutations are not stopped) may be made a bit more explicit if possible. We could probably include a "Whereas.." line that refers to that explicitly.

Best regards, Bram

-----Original Message----- From: Npos_2018 npos_2018-bounces@testbiotech.de On Behalf Of Fulya BATUR Sent: Friday, 3 September 2021 12:11 To: Christoph Then info@no-patents-on-seeds.org; npos_2018@testbiotech.de Subject: Re: [Npos_2018] important draft resolution for EU, deadline Wednesday

Hello all,

Please find hereby attached my comments and suggestions (in track changes) for the future EP Resolution, thanks for your patience!

There are not many, mostly editing, providing some context, and attempting to better differentiate between the issues of patentability itself and scope. We could clearly push more against new GM, but the concrete examples that you provide will for sure be helpful for MEP's to pick up on the subject.

Do not hesitate to get in touch if some things are unclear.

Best

Fulya

Fulya BATUR, PhD Consultancy, Training, Research & Legal Advice https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.kybele-... 0032.484.77.86.18

Do you want to receive updates on policy developments that affect the crop biodiversity movement in Europe? Subscribe to the monthly newsletter Sprouts from Brussels !

-----Original Message----- From: Npos_2018 npos_2018-bounces@testbiotech.de On Behalf Of Christoph Then Sent: Monday, 30 August 2021 08:57 To: npos_2018@testbiotech.de Subject: [Npos_2018] important draft resolution for EU, deadline Wednesday

Dear all

please see attached a draft resolution for the European Parliament. I am trying to reach out for the Greens and as soon as they respond (or not respond), I also will inform some Social Democrats.

I had a look onto the previous resolutions and took over some elements. I added the need for definition of essentially biological processes and limiting scope of patents.

I also added two procedural issues, based on Article 4(a) of the EPC (conference of ministers every five years) and Article 16 of the EU directive (annual reports).

To me it looks important that the EP gets aware of the risk that CRISPR industry will take over conventional breeding if patents on random mutations are not stopped. This is also an issue for the Green Deal.

please come back to me with your first comments if needed till Wednesday.

thanks,

Christoph